Sacituzumab govitecan is recommended by Oncologists for the management and treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer. This is considered as a significant option for patients who are not ideal candidates for certain conventional therapies. Trodelvy 200mg is the new available commercial strength. It used to be also available as Trodelvy 180mg vials. Immunomedics is credited for the development of this advanced medication. Gilead Sciences promotes and facilitates access to Sacituzumab internationally. Sacituzumab govitecan Price in India depends on the international factors. Its access will be specific to the patients who are recommended for an FDA approved indication.
Sacituzumab Govitecan FDA and EMA Approval details
Sacituzumab govitecan received its accelerated US FDA approval in 2020 for treating metastatic triple-negative breast cancer (mTNBC) patients. In April 2021, it was granted the regular approval for treating locally advanced or metastatic mTNBC patients who received at least two prior therapies. This makes it an advanced option that can be used at a later stage of cancer management, providing more scope for survival benefits. Trodelvy received its EMA approval in October 2021.
- Referred as a first-in-class medicine for the treatment of aggressive form of Breast Cancer, Sacituzumab is ideal for unresectable adult patients. When surgery or resection is not an option, chemotherapy and other immunotherapy agents are strategically used for the better disease management.
- Trodelvy (Sacituzumab govitecan) was also given the accelerated approval for Locally Advanced or Metastatic Urothelial Cancer by the US FDA in April 2021. This was the second FDA approval for it in the same year. The scope of expanding its use for other forms of cancer is being studied.
Trodelvy in India – Information about sourcing process
Queries similar to Trodelvy Cost in India can be addressed based on the systems and procedures available for its sourcing. The cost of Trodelvy can be worked out based on the accurate recommendation by the treating physicians. Before anything, the suitability or eligibility of Sacituzumab has to be confirmed. Not all patients with the same indication may be the ideal candidates for it. The treatment planning shall be done based on the patient assessment and accordingly the ideal dose along with the number of cycles shall be prescribed. Based on the quantity required, Sacituzumab cost in India can be calculated. It is all the more important for the patients to be sure about the suppliers they are working with. Many traders who do not have the authorization to handle certain lifesaving medicines are often found to be promoting them. They may have attractive offers for Trodelvy Price in India, but can’t be relied upon because they are not licensed. When it is about health, all the choices must be based on the absolute health benefits.
Reliable procurement of Trodelvy (Sacituzumab govitecan)
Those who are recommended to procure Sacituzumab in India should first get the import permit to proceed further with sourcing and logistics arrangements. CDSCO is the government authorized portal that can be used to apply for an online permit. Documents including the prescription can be uploaded and certain details like the country of procurement should be furnished in the forms specified by them. Patients can take the assistance of experienced professionals to save time and hassle with the procedures, if necessary.
Contact Noel Biotech – +91 9677010046 / +91 992977766; nhs@noelbiotech.com